{"name":"Causeway Therapeutics","slug":"causeway-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxONm9MTThFeDAtQ0k2cENEV04wcWlWSW9aLUJnd1A3VlJWeGhLcENoYmRSR1dfT0FhY0gtUzI4eDVGSGtReTNCN09NbXAyX0JpOHNwdlBIcktzRGZlLXhLQXlrei1HU3prVS01MnFidEY4Q1d6UXpaREVlZEtpbUFncWtVYy0yX2VITm5WMl8ya19WTnFnREJRN1p3?oc=5","date":"2026-03-19","type":"pipeline","source":"富途牛牛","summary":"Processa Pharmaceuticals | 10-K: FY2025 Annual Report - 富途牛牛","headline":"Processa Pharmaceuticals | 10-K: FY2025 Annual Report - 富途牛牛","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQVVhlVE5UbDBsV2lIdEo2TC1TeHhSTlJFWjdfOHF1Ul9CUnJ1VElKdUpoSUlFS2kzN3VjM3FDWElfeXk2Ym54VTNtejA3SkZNUjFKRm9qRnNpNXcxM3pfZlEzUE9jQjdxLTV5V3RvaGdsYTBpUkJWLTVhZHRXNS1STUx6R19XUjJHa3ZUeHZEVFNXT1JoUjhSbTZUYldQdHEtcnUyTGFUdFlzaHAweWkyWTVuemhBcDdGR1VNbHpIUGYtWm5F?oc=5","date":"2026-03-18","type":"pipeline","source":"富途牛牛","summary":"Universe Pharmaceuticals | 3: Initial statement of beneficial ownership of securities- Lai Gang - 富途牛牛","headline":"Universe Pharmaceuticals | 3: Initial statement of beneficial ownership of securities- Lai Gang - 富途牛牛","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBIaFVsWnM5bTlVMVFPWEFsVFhUME1JdzltT05rZ1lkSjVZQml3V2xQQ2o3d0E1MlJVYlBqTnlIQ20wdWJLUlVDU3lDTWNic3hVb09nX3ZHejhnRld6VzJyeV9BSUoyTFpGY3pzUzViRnhkTjQzMDdLdzRoVnV5Z9IBgwFBVV95cUxNUXVjMFhEd1pHQkV1VHlCRjNjdDNpdnplbnV4OW1JWUxVZk5tb1Jod0Rfa08ydnRmT3ZNV204UEd4R2NuNUdqRjlsNUk3Q0R1ajgwMExzVmZoZmM4QXFVc3lfWlItUzVfUE50YXMwNUtFWEp5cS1Gem5jdkZ5eEVLaVdzWQ?oc=5","date":"2025-12-08","type":"pipeline","source":"Pulse 2.0","summary":"Causeway Therapeutics: Interview With CEO & Executive Chairman Declan Doogan About Developing microRNA-Based Therapies - Pulse 2.0","headline":"Causeway Therapeutics: Interview With CEO & Executive Chairman Declan Doogan About Developing microRNA-Based Therapies -","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPS01ra3dWY0NSdEx0VmNmU3NOUDk2ekpyaDZreTBGcENRMEc4VThCLWRxTGZnTWV4emJ0NDlWSzR3c2NmOElOcGw4c1VrdHJEdHdCRXNpNTNaQ1hVb1UtZ0FCS2RsWXhTNlhENFNMcWpqYWRXb3NUMUhJUjdvMmZwZNIBhgFBVV95cUxQTnFVYVBxYVlJQzY3SWhrY0NoZkJ3NndsQml3YjlGTkt0b2FseDhZUXJoUHlPVmpSNmUzQWswUzVQMUt4c1N0U2UtX00wdzV3LWFSU2xFa095SDNRNnpSY1JOS1pJbHhkVDB1cHV3d1g4VTdENVQzck9JZnJsem5oQ3dyVEx1UQ?oc=5","date":"2023-02-27","type":"trial","source":"Insider.co.uk","summary":"Glasgow university spin-out secures £8.75 million for tennis elbow treatment trials - Insider.co.uk","headline":"Glasgow university spin-out secures £8.75 million for tennis elbow treatment trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMVdpck81TnhJTG9pRGRTOEtjXzE0Z3hkYnR2YXNrUUFoQ0lqTG1GX3lEdWlPQjJRaVJobDJHRWRBUjVyV3p0d2htLUpEN1A0dWFXTThkNk5Ea1RYNWlzRVRiYVlfXzRjcGRxbGEtdE16ZVFSLVpOLU42Y2xqTDhGenhLTVJPUVNUMkZMcG13elZmS0ktbXhBeEVGdjVKUEw3QWZuMkFoSmNHVXF3cjdV?oc=5","date":"2018-09-27","type":"trial","source":"scottish-enterprise-mediacentre.com","summary":"Scottish Investment Bank case study: Causeway Therapeutics - scottish-enterprise-mediacentre.com","headline":"Scottish Investment Bank case study: Causeway Therapeutics - scottish-enterprise","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}